A Study of mRNA-4359 in People With Solid Tumor Cancer

Full Title

Phase 1/2 Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants with Advanced Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Who Can Join

For more information or to see if you can join this study, please call Dr. James Smithy’s office at 646-888-6782 .

Protocol
26-134
Phase
Phase I/II (phases 1 and 2 combined)
Investigator
James W. Smithy
Co-Investigators
Michael A. Postow
Diseases
Melanoma
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT05533697
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description